TrialAmerican journal of clinical dermatology2022

Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.

Linda Stein Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.